The Paternal Age Effect - Enhanced Germ Cell Mutagenesis Modulated by the TRP53/APE1/MDM2 Tumor Suppressor Axis
父亲年龄效应 - TRP53/APE1/MDM2 肿瘤抑制轴调节的增强生殖细胞诱变
基本信息
- 批准号:10264033
- 负责人:
- 金额:$ 36.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:APEX1 geneAddressAgeAgingAnimalsAutomobile DrivingBase Excision RepairsBiologicalBirthBirth RateCell divisionCellsChildChild HealthChromatinChromosomesChronicDNA DamageDNA RepairDNA sequencingDataDiagnosisEmbryonic DevelopmentEnzymesEpidemicFathersFertilityFrequenciesGenerationsGenesGeneticGenetic DiseasesGenetic RiskGenotypeGerm CellsGerm-Line MutationGoalsImmunofluorescence MicroscopyImmunoprecipitationInfertilityInterventionKnock-outKnockout MiceLabelLifeLinkMDM2 geneMass Spectrum AnalysisMediatingMeiosisMethodologyMethodsMitoticModelingMusMutagenesisMutationNational Institute of Child Health and Human DevelopmentPaintPaternal AgePhosphorylationPhysiologyPlayPopulationProteinsReproductionResearchRiskRisk FactorsRoleSignal TransductionSiteSpermatidsSpermatocytesSpermatogenic CellTP53 geneTestingTranscription CoactivatorTransgenic MiceTransgenic OrganismsTumor Suppressor ProteinsUbiquitinationage effectautism spectrum disorderbasecell typechromatin proteincytotoxicdriving forceendonucleasegenome integrityhuman old age (65+)in vivoinhibitor/antagonistinnovationinsightmalemenmiddle agemulticatalytic endopeptidase complexmutantnovelolder menoverexpressionpreservationrepairedreproductivereproductive senescencesenescencesperm cellstem cell agingtranscription factoryoung adultyoung man
项目摘要
PROJECT SUMMARY
Birth rates to older fathers increased approximately 60% since 1980, while births to younger fathers declined. Of
the nearly 4 million registered births in 2015, 11% (~440,000) were born to older fathers. Sperm from older men
have more mutations compared with young men, increasing the risk that their children will be afflicted with a
genetic disease. This increase in mutations, the paternal age effect, is increasingly significant and is directly
relevant to male reproductive aging and to child health. DNA repair declines in spermatogenic cells as mice age,
promoting an increase in mutations. Reduced levels of a base excision repair protein is causal to reduced repair
activity and increased mutagenesis in spermatogenic cells at older age. Our preliminary data indicate the
mechanisms driving increased germline mutagenesis with aging occur in meiotic pachytene spermatocytes and
involve APEX1, TRP53 and MDM2, tumor suppressors that normally function to protect against mutagenesis.
We hypothesize that chronic activation of TRP53 activates MDM2 ubiquitination of APEX1, resulting in reduced
APEX1. In Aim 1 we will test if phosphorylation of TRP53 at Ser18/23 triggers degradation of APEX1 in
pachytene spermatocytes, but not post-meiotic round spermatids, from older mice. In Aim 2. we will test if MDM2
ubiquitinates APEX1, leading to greater amounts of highly ubiquitinated APEX1 in pachytene spermatocytes,
not round spermatids, of older mice, proteasomal degradation of APEX1, and a resulting greater spontaneous
mutation frequency. In Aim 3, based upon preliminary data showing a unique distribution of APEX1, we will test
if APEX1 uniquely interacts with chromatin in meiotic cells. Methods: Defined populations of enriched specific
spermatogenic cell types will be prepared from male mice carrying targeted genetic changes in Mdm2 and Trp53
to test whether 1) these tumor suppressors dysregulate APEX1 abundance in old mice, and 2) become
chronically activated during aging resulting in decreased APEX1 abundance, decreased base excision repair,
and increased mutagenesis. The importance of proteasome degradation and MDM2 activity will be tested using
proteasome and MDM2 inhibitors. Proximity labeling will be used in vivo to identify APEX1 interacting proteins
in meiotic cells. Age-associated mutation frequency and spectra will be determined for mouse genes using
duplex sequencing. The proposed studies test a novel model in which a tumor suppressor axis (i.e. TRP53,
MDM2 and APEX1) that normally functions to safeguard genome integrity, instead compromises gamete genetic
quality by reducing APEX1 abundance and resulting in elevated mutagenesis in the unique biological context of
aging meiotic germ cells. If confirmed, this is a paradigm shift from the widely held view that the major driving
force of increased mutations in male gametes is a passive accumulation. The proposed studies will address a
fundamental biological mechanism driving increased mutagenesis that leads to the paternal age effect and may
ultimately reveal potential treatment targets to protect against genetic diseases mediated through mutagenesis
in spermatogenic cells.
项目摘要
自1980年以来,年龄较大的父亲的出生率增长了约60%,而对年轻父亲的出生下降。的
2015年的近400万注册出生,较老的父亲出生了11%(〜440,000)。老年男子的精子
与年轻人相比,有更多的突变,增加了孩子的风险
遗传疾病。突变的增加,父亲年龄的效应,越来越重要,直接
与男性生殖衰老和儿童健康有关。随着小鼠的年龄,DNA修复在生精细胞中的下降,
促进突变的增加。碱基切除修复蛋白的降低是为了减少修复的因果
年龄较大的精子生成细胞中的活性和诱变增加。我们的初步数据表明
在减数分裂的精子细胞中,驱动的机制随着衰老而增加了种系诱变,并且
涉及APEX1,TRP53和MDM2,通常功能可防止诱变的肿瘤抑制剂。
我们假设TRP53的慢性激活激活了Apex1的MDM2泛素化,从而减少了
Apex1。在AIM 1中,我们将测试在Ser18/23处Trp53的磷酸化是否在Apex1中的触发下降
pachytene的精子细胞,但不是来自老鼠的脂肪生成后圆形精子。在AIM 2中。我们将测试MDM2是否
泛素化Apex1,导致pachytene精子细胞中的高度泛素化APEX1,
不是圆形的小鼠的圆形精子,Apex1的蛋白酶体降解和自发性更大的自发性
突变频率。在AIM 3中,根据显示Apex1独特分布的初步数据,我们将测试
如果Apex1在减数分裂细胞中与染色质唯一相互作用。方法:定义的富集特定种群
将从携带MDM2和TRP53中靶向遗传变化的雄性小鼠制备精子细胞类型
测试1)这些肿瘤抑制剂是否使老鼠的Apex1丰度失调,而2)
长期激活在衰老过程中,导致Apex1丰度降低,碱性切除修复减少,
并增加诱变。蛋白酶体降解和MDM2活性的重要性将使用
蛋白酶体和MDM2抑制剂。接近标记将在体内使用来识别APEX1相互作用蛋白
在减数分裂细胞中。使用年龄相关的突变频率和光谱将用于小鼠基因
双工测序。提出的研究测试了一个新型模型,其中肿瘤抑制轴(即TRP53,
MDM2和APEX1)通常起作用以保护基因组完整性,而是损害了配子遗传
通过减少Apex1丰度,并在独特的生物学环境中升高诱变来质量
减素生殖细胞衰老。如果得到确认,这是从主要驾驶的广泛观点的范式转变
男配子中突变增加的力是被动积累。拟议的研究将解决
驱动的基本生物学机制增加了诱变,从而导致父亲年龄的影响,并且可能
最终揭示了潜在的治疗靶标,以防止通过诱变介导的遗传疾病
在生精细胞中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christi A Walter其他文献
Christi A Walter的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christi A Walter', 18)}}的其他基金
The Paternal Age Effect - Enhanced Germ Cell Mutagenesis Modulated by the TRP53/APE1/MDM2 Tumor Suppressor Axis
父亲年龄效应 - TRP53/APE1/MDM2 肿瘤抑制轴调节的增强生殖细胞诱变
- 批准号:
10436348 - 财政年份:2020
- 资助金额:
$ 36.07万 - 项目类别:
The Paternal Age Effect - Enhanced Germ Cell Mutagenesis Modulated by the TRP53/APE1/MDM2 Tumor Suppressor Axis
父亲年龄效应 - TRP53/APE1/MDM2 肿瘤抑制轴调节的增强生殖细胞诱变
- 批准号:
10646448 - 财政年份:2020
- 资助金额:
$ 36.07万 - 项目类别:
The Paternal Age Effect - Enhanced Germ Cell Mutagenesis Modulated by the TRP53/APE1/MDM2 Tumor Suppressor Axis
父亲年龄效应 - TRP53/APE1/MDM2 肿瘤抑制轴调节的增强生殖细胞诱变
- 批准号:
10091650 - 财政年份:2020
- 资助金额:
$ 36.07万 - 项目类别:
Tumor Suppressors Mediate a Reduction in Male Gamete Quality with Aging
肿瘤抑制剂介导雄性配子质量随着衰老而降低
- 批准号:
9564362 - 财政年份:2017
- 资助金额:
$ 36.07万 - 项目类别:
Mitochondrial DNA Damage: Cellular Responses, Aging and Disease
线粒体 DNA 损伤:细胞反应、衰老和疾病
- 批准号:
8195926 - 财政年份:2010
- 资助金额:
$ 36.07万 - 项目类别:
Mitochondrial DNA Damage: Cellular Responses, Aging and Disease
线粒体 DNA 损伤:细胞反应、衰老和疾病
- 批准号:
7930438 - 财政年份:2010
- 资助金额:
$ 36.07万 - 项目类别:
Mitochondrial DNA Damage: Cellular Responses, Aging and Disease
线粒体 DNA 损伤:细胞反应、衰老和疾病
- 批准号:
8259063 - 财政年份:2010
- 资助金额:
$ 36.07万 - 项目类别:
Mitochondrial DNA Damage: Cellular Responses, Aging and Disease
线粒体 DNA 损伤:细胞反应、衰老和疾病
- 批准号:
8397515 - 财政年份:2010
- 资助金额:
$ 36.07万 - 项目类别:
Base Excision Repair, Genetic Integrity & Health Span
碱基切除修复、遗传完整性
- 批准号:
7109417 - 财政年份:2004
- 资助金额:
$ 36.07万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Paternal Age Effect - Enhanced Germ Cell Mutagenesis Modulated by the TRP53/APE1/MDM2 Tumor Suppressor Axis
父亲年龄效应 - TRP53/APE1/MDM2 肿瘤抑制轴调节的增强生殖细胞诱变
- 批准号:
10436348 - 财政年份:2020
- 资助金额:
$ 36.07万 - 项目类别:
The Paternal Age Effect - Enhanced Germ Cell Mutagenesis Modulated by the TRP53/APE1/MDM2 Tumor Suppressor Axis
父亲年龄效应 - TRP53/APE1/MDM2 肿瘤抑制轴调节的增强生殖细胞诱变
- 批准号:
10091650 - 财政年份:2020
- 资助金额:
$ 36.07万 - 项目类别:
Tumor Suppressors Mediate a Reduction in Male Gamete Quality with Aging
肿瘤抑制剂介导雄性配子质量随着衰老而降低
- 批准号:
9564362 - 财政年份:2017
- 资助金额:
$ 36.07万 - 项目类别:
Role of SAMe on UBC9 and sumolyation in liver cancer and alcoholic liver injury
SAMe 对 UBC9 的作用以及肝癌和酒精性肝损伤中的求和作用
- 批准号:
8147672 - 财政年份:2010
- 资助金额:
$ 36.07万 - 项目类别:
ROLE OF S-ADENOSYLMETHIONINE ON UBC9 AND SUMOYLATION IN LIVER CANCER AND ALCOHOLI
S-腺苷甲硫氨酸对 UBC9 的作用以及肝癌和酒精中的苏酰化
- 批准号:
8061618 - 财政年份:2010
- 资助金额:
$ 36.07万 - 项目类别: